Investor Relations



Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical, and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts.

Hologic employs approximately 5,500 employees worldwide. The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".


Monday, September 8, 2014
Hologic 3D Mammography Receives Highest Performance Rating of Over 100 Products Evaluated in the "Best in KLAS" Awards - Two Years Running
Read Release


Tuesday, September 2, 2014
Hologic to Present at Morgan Stanley Global Healthcare Conference
Read Release
Listen to Webcast

Thursday, July 31, 2014
Hologic President and CEO Steve MacMillan on CNBC Squawk Box
View Video


Wednesday, July 30, 2014
Hologic Announces Third Quarter Fiscal 2014 Operating Results
Read Release
View Presentation


Wednesday, July 9, 2014
Hologic to Release Third Quarter Fiscal 2014 Operating Results on Wednesday, July 30, 2014
Read Release

Comments? Please fill out our Feedback Form and let us know how you like our Investor website.